Belarusians drugs will reach 55% of the market share
In value terms, by the year 2020 the share of Belarusian medicines in the domestic market must achieve at least 55%, according to the development program of the pharmaceutical industry for the years 2016-2020. Now the share of Belarussian production drugs is situated at 52.7%.
Among other objectives for the next five years for the pharmaceutical industry: the growth of Belarusian drugs exports, the development of “new approaches to the development of marketing activities” for selling drugs in the domestic market in addition to the reduction of the production costs by 25%.
It is important to recall that in February 2015, the President of Belarus Alexander Lukashenko demanded to provide the population with “the affordable high quality medicines of domestic production.”
Apart from the share of Belarusian medicines, the national Ministry of Health discussed the possibility of “price formation”. In other words, the formation of the final price will decouple the dollar and will be referenced to the base value in Belarusian rubles. The Ministry of Health is preparing necessary changes in the presidential Decree No. 366 of 11 August 2005 for the formation of prices of medicines, medical devices and medical equipment.